Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|January 31, 2017
Top-down approach to biological therapy of Crohn's diseaseSimon Hirschmann, Markus F Neurath
Allergo Journal International|June 30, 2015
Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intoleranceMarkus Hahn, Alexander F Hagel, Simon Hirschmann, et al.
Frontiers in Immunology|July 19, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression ProfilesFriederike Fuchs, Daniela Schillinger, Raja Atreya, et al.
Therapeutic Advances in Gastroenterology|October 7, 2021
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndromeSimon Hirschmann, Sarah Fischer, Entcho Klenske, et al.
Endoscopy International Open|August 13, 2019
Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel diseaseEntcho Klenske, Raja Atreya, Arndt Hartmann, et al.
Archivum Immunologiae Et Therapiae Experimentalis|August 27, 2014
Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitisStefanie Steiner, Carolin Daniel, Anika Fischer, et al.
Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.
Therapeutic Advances in Gastroenterology|October 26, 2020
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitisIngo Ganzleben, Carol Geppert, Lourdes Osaba, et al.
Gut|July 26, 2015
Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivoAnika Fischer, Sebastian Zundler, Raja Atreya, et al.
BMC Gastroenterology|April 16, 2020
Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort studyClarissa Allner, Michaela Melde, Emily Becker, et al.
Pageof 2